ODI Pharma's vision
Get to know us better
ODI Pharma Group (“ODI”) was founded in 2018 with the goal to improve patients access to medicinal cannabis. Based on its European network, subsidiaries and partners, ODI is a producer and representative of pharmaceutical cannabis finished products under governmental supervision and regulation with a focus on distribution to medicinal markets, initially targeting Eastern Europe. ODI’s products are to be sold to clients and patients through ODI's relationships to wholesale medical distributors representing nearly all of Eastern Europe’s hospitals, clinics and pharmacies. ODI does not strive to cultivate the raw product itself, but decided to team up with the global leaders in the industry to source highest quality product for ODI’s and its client's brands, thereby ensuring reliability, consistency and professionalism.

Executive Team

Volker Wiederrich
Chairman of the Board

Jan-Mark
Edewaard
CEO
Member of the Board

Karina
Kilinski
Sales Director
Member of the Board

Gösta
Lidén
Member of the Board

Dr. Markus Fritzsche
Research Director
Volker Wiederrich
Chairman of the Board
Volker Wiederrich, born 1980, has an extensive background in investment and asset management across multiple asset classes. Mr. Wiederrich has 18 years of experience advising one of the biggest financial institutions of Europe on investments in real estate funds, as well as 13 years as Chief Investment Officer for an advisory firm for infrastructure and real estate within a global capacity. Mr. Wiederrich advised on more than 1bn USD in investments and was managing multiple fund products during his career. Volker graduated with a MSc. in Economics.
Jan-Mark
Edewaard
CEO and Member of the Board
Mr. Edewaard holds a bachelor's degree in Management, Economics & Law. After having worked in a variety of finance positions, he was active as an internal auditor in two large international corporations for a period of time. In 2009 Mr. Edewaard took responsibility for Finance and Accounting in a Dutch ship owning company. In 2011 he moved to an associated company, also active in chemical tanker shipping, to take on the role of CFO. Mr. Edewaard contributed strongly to the development of that company, in close cooperation with the CEO. Until 2019 he remained in the position of CFO and for the past 5 years in the position of General Manager
Karina Kilinski
Member of the Board
Karina Kilinski has 19 years of experience trading commodities and goods between Poland and Germany/Switzerland, as well as 15 years of running local Polish production and distribution companies. Mrs. Kilinski also has 19 years of funding and running online trading and retail sales businesses.